Garo Armen - Agenus Chairman of the Board, CEO
| AJ81 Stock | EUR 7.80 0.00 0.00% |
Chairman
Dr. Garo H. Armen, Ph.D., is the founder, Chairman of the Board and Chief Executive Officer of Agenus Inc. Dr. Armen is Chairman and Chief Executive Officer of Agenus Inc., which he cofounded in 1994. Dr. Armen brings to our Board a deep historical and practical knowledge of the business of the Company and its technologies, as well as years of expertise in the financial and biopharmaceutical arenas. From mid2002 through 2004, he was Chairman of the Board of Directors for the biopharmaceutical company Elan Corporationrationration, plc which he helped restructure. Dr. Armen currently serves as nonexecutive Chairman of the Board of Directors of Protagenic Therapeutics, Inc., a publicly held biotechnology company since 1994.
| Age | 70 |
| Tenure | 30 years |
| Professional Marks | Ph.D |
| Phone | 781 674 4400 |
| Web | https://www.agenusbio.com |
Garo Armen Latest Insider Activity
Tracking and analyzing the buying and selling activities of Garo Armen against Agenus stock is an integral part of due diligence when investing in Agenus. Garo Armen insider activity provides valuable insight into whether Agenus is net buyers or sellers over its current business cycle. Note, Agenus insiders must abide by specific rules, including filing SEC forms every time they buy or sell Agenus'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Garo Armen few days ago Acquisition by Garo Armen of 3080 shares of Agenus at 5.31 subject to Rule 16b-3 | ||
Garo Armen over a month ago Acquisition by Garo Armen of 27163 shares of Agenus at 0.55 subject to Rule 16b-3 | ||
Garo Armen over a month ago Acquisition by Garo Armen of 22136 shares of Agenus at 0.67 subject to Rule 16b-3 | ||
Garo Armen over six months ago Purchase by Garo Armen of 100000 shares of Mink Therapeutics |
Agenus Management Efficiency
The company has return on total asset (ROA) of (0.2577) % which means that it has lost $0.2577 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (18.903) %, meaning that it generated substantial loss on money invested by shareholders. Agenus' management efficiency ratios could be used to measure how well Agenus manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 1 records | CHAIRMAN Age | ||
| Bruce Karsh | NorAm Drilling AS | 60 | |
Management Performance
| Return On Equity | -18.9 | |||
| Return On Asset | -0.26 |
Agenus Inc Leadership Team
Elected by the shareholders, the Agenus' board of directors comprises two types of representatives: Agenus inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Agenus. The board's role is to monitor Agenus' management team and ensure that shareholders' interests are well served. Agenus' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Agenus' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert Stein, Chief Scientific Officer | ||
| James Gorman, Vice President - Strategic Planning and Portfolio Management | ||
| Ozer Baysal, Chief Business Officer | ||
| Regina Grebla, VP Communications | ||
| Shalini Sharp, Director | ||
| John Castle, Head Bioinformatics | ||
| Wadih Jordan, Independent Director | ||
| Christine Klaskin, Principal Financial Officer, Principal Accounting Officer, Vice President - Finance | ||
| Jennifer Buell, Pres Therapeutics | ||
| Don Vidic, Vice President Head of Commercial | ||
| Brian Corvese, Independent Director | ||
| Karen Valentine, Vice President Chief Compliance Officer, General Counsel, Secretary | ||
| Evan Ballantyne, CFO | ||
| Timothy Wright, Lead Independent Director | ||
| Christian Cortis, Chief Strategy Officer and Head of Finance | ||
| Julie DeSander, Chief Officer | ||
| Ulf Wiinberg, Director | ||
| Alexander Duncan, CTO and Head - Research | ||
| Tracy Clemente, Chief Officer | ||
| Allison JeynesEllis, Director | ||
| Garo Armen, Chairman of the Board, CEO | ||
| JeanMarie Cuillerot, Chief Medical Officer | ||
| Andrea Rabney, IR Contact Officer | ||
| Craig Winter, Chief Officer | ||
| Robin JD, Chief Officer | ||
| Shahzad Malik, Independent Director | ||
| Evan Kearns, Vice President General Counsel, Secretary |
Agenus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Agenus a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -18.9 | |||
| Return On Asset | -0.26 | |||
| Profit Margin | (2.39) % | |||
| Operating Margin | (1.99) % | |||
| Current Valuation | 646 M | |||
| Shares Outstanding | 304.81 M | |||
| Shares Owned By Insiders | 8.96 % | |||
| Shares Owned By Institutions | 65.26 % | |||
| Price To Earning | (3.13) X | |||
| Price To Book | 181.30 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Agenus in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Agenus' short interest history, or implied volatility extrapolated from Agenus options trading.
Pair Trading with Agenus
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Agenus position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agenus will appreciate offsetting losses from the drop in the long position's value.Moving against Agenus Stock
| 0.7 | TM2 | Sydbank A/S | PairCorr |
| 0.69 | 0QF | Moderna | PairCorr |
| 0.64 | SON1 | Sony Group Corp | PairCorr |
| 0.64 | BFP | BBVA Banco Frances | PairCorr |
| 0.56 | MIZ | Mizuno | PairCorr |
The ability to find closely correlated positions to Agenus could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Agenus when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Agenus - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Agenus Inc to buy it.
The correlation of Agenus is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Agenus moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Agenus Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Agenus can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. Note that the Agenus Inc information on this page should be used as a complementary analysis to other Agenus' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Agenus Stock analysis
When running Agenus' price analysis, check to measure Agenus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Agenus is operating at the current time. Most of Agenus' value examination focuses on studying past and present price action to predict the probability of Agenus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Agenus' price. Additionally, you may evaluate how the addition of Agenus to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |